| dbo:abstract |
Metodesnitazene (also known as Metazene) is a benzimidazole derivative with opioid effects, though unlike related compounds such as metonitazene and etodesnitazene which are many times more potent, metodesnitazene is only around the same potency as morphine in animal studies. It was proposed by the DEA to be placed under legal control in the US in December 2021. (en) |
| dbo:casNumber |
1071546-40-1 (HCl) 14030-77-4 |
| dbo:pubchem |
26412 |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Metodesnitazene_structure.png?width=300 |
| dbo:wikiPageID |
69607278 (xsd:integer) |
| dbo:wikiPageLength |
3716 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1082990966 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:List_of_benzimidazole_opioids dbr:Benzimidazole dbc:Analgesics dbc:Designer_drugs dbc:Opioids dbr:Morphine dbc:Aromatic_ethers dbc:Benzimidazoles dbr:Etodesnitazene dbr:Isotonitazene dbr:Metonitazene dbr:Opioid dbr:Etonitazepyne |
| dbp:c |
21 (xsd:integer) |
| dbp:casNumber |
14030 (xsd:integer) |
| dbp:casSupplemental |
1071546 (xsd:integer) |
| dbp:drugName |
Metodesnitazene (en) |
| dbp:h |
27 (xsd:integer) |
| dbp:iupacName |
N,N-diethyl-2-[2-[methyl]benzimidazol-1-yl]ethanamine (en) |
| dbp:legalUk |
PSA (en) |
| dbp:legalUs |
Schedule I (en) |
| dbp:n |
3 (xsd:integer) |
| dbp:o |
1 (xsd:integer) |
| dbp:pubchem |
26412 (xsd:integer) |
| dbp:smiles |
CCNCCN1C2=CC=CC=C2N=C1CC3=CC=COC (en) |
| dbp:stdinchi |
1 (xsd:integer) |
| dbp:stdinchikey |
SFNKTTXBZXVGOH-UHFFFAOYSA-N (en) |
| dbp:wikiPageUsesTemplate |
dbt:Analgesic-stub dbt:Drugbox dbt:Reflist dbt:Short_description dbt:Opioids |
| dct:subject |
dbc:Analgesics dbc:Designer_drugs dbc:Opioids dbc:Aromatic_ethers dbc:Benzimidazoles |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Drug |
| rdfs:comment |
Metodesnitazene (also known as Metazene) is a benzimidazole derivative with opioid effects, though unlike related compounds such as metonitazene and etodesnitazene which are many times more potent, metodesnitazene is only around the same potency as morphine in animal studies. It was proposed by the DEA to be placed under legal control in the US in December 2021. (en) |
| rdfs:label |
Metodesnitazene (en) |
| owl:sameAs |
wikidata:Metodesnitazene https://global.dbpedia.org/id/FZK47 |
| prov:wasDerivedFrom |
wikipedia-en:Metodesnitazene?oldid=1082990966&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Metodesnitazene_structure.png |
| foaf:isPrimaryTopicOf |
wikipedia-en:Metodesnitazene |
| foaf:name |
Metodesnitazene (en) |
| is dbo:wikiPageWikiLink of |
dbr:List_of_benzimidazole_opioids dbr:List_of_designer_drugs dbr:Etodesnitazene dbr:Opioid |
| is foaf:primaryTopic of |
wikipedia-en:Metodesnitazene |
